Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
15
Bearish filings
0
Named actors
1
Disclosed $ (bull / bear)
$15K / $0
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-16 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $523 | SEC ↗ |
| 2026-09-10 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $175 | SEC ↗ |
| 2026-09-04 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $479 | SEC ↗ |
| 2026-09-02 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $147 | SEC ↗ |
| 2026-08-31 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $172 | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-24 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $116 | SEC ↗ |
| 2026-08-20 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $518 | SEC ↗ |
| 2026-08-19 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $590 | SEC ↗ |
| 2026-08-14 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $112 | SEC ↗ |
| 2026-08-07 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $501 | SEC ↗ |
| 2025-12-17 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $498 | SEC ↗ |
| 2025-11-20 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $3K | SEC ↗ |
| 2025-11-20 | Director CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $8K | SEC ↗ |
| 2025-10-31 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $420 | SEC ↗ |
| 2025-09-23 | CEO CTT PHARMACEUTICAL HOLDINGS, INC. | bought | $409 | SEC ↗ |